Belite Bio (BLTE) Shares Outstanding (Diluted) (2020 - 2026)
Belite Bio's Shares Outstanding (Diluted) was 33.54 million in Q2 2026, up 9.8% from 30.54 million a year earlier and unchanged from the prior quarter.
Powered by 
Analysis
Belite Bio (BLTE) Shares Outstanding (Diluted) (2020 - 2026) Analysis & Trends
From Q4 2020 onward, Belite Bio has reported Shares Outstanding (Diluted) for 20 quarters.
- Shares Outstanding (Diluted) has now increased for five consecutive years, with a five-year compound annual growth rate of 30.7% (FY2020 to FY2025).
- In earlier years, Shares Outstanding (Diluted) was 30.54 million in FY2024 (+14.8%), 26.59 million in FY2023 (+33.1%), 19.98 million in FY2022 (+108.7%) and 9.57 million in FY2021 (+8.9%).
- Compared with a year earlier, Shares Outstanding (Diluted) has increased for 15 straight quarters, with growth averaging 15.2% over the last eight quarters.
- Across the past five years, year-over-year growth in Shares Outstanding (Diluted) ran from 8.9% in Q4 2021 to 108.7% in Q3 2023.
- Per Business Quant data, BLTE's Shares Outstanding (Diluted) in the three quarters before Q2 2026 was 33.54 million (Q1 2026), 33.54 million (Q4 2025) and 30.54 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Outstanding (Dil.) (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 2.44 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | 1.77 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 2.47 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | 1.96 Bn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | 1.56 Bn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 544.00 Mn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | 1.24 Bn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | 5.70 Bn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 255.20 Mn |
| 10 | Belite Bio | 6.68 Bn | 6.68 Bn | - | 33.54 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 33.54 Mn |
| Mar 31, 2026 | 33.54 Mn |
| Dec 31, 2025 | 33.54 Mn |
| Sep 30, 2025 | 30.54 Mn |
| Jun 30, 2025 | 30.54 Mn |
| Mar 31, 2025 | 30.54 Mn |
| Dec 31, 2024 | 30.54 Mn |
| Sep 30, 2024 | 26.59 Mn |
| Jun 30, 2024 | 26.59 Mn |
| Mar 31, 2024 | 26.59 Mn |
| Dec 31, 2023 | 26.59 Mn |
| Sep 30, 2023 | 19.98 Mn |
| Jun 30, 2023 | 19.98 Mn |
| Mar 31, 2023 | 19.98 Mn |
| Dec 31, 2022 | 19.98 Mn |
| Sep 30, 2022 | 9.57 Mn |
| Jun 30, 2022 | 9.57 Mn |
| Mar 31, 2022 | 9.57 Mn |
| Dec 31, 2021 | 9.57 Mn |
| Dec 31, 2020 | 8.79 Mn |
API Access
Belite Bio Shares Outstanding (Diluted) API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=shares-outstanding-diluted&ticker=BLTE&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "shares-outstanding-diluted", "ticker": "BLTE", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=shares-outstanding-diluted&ticker=BLTE&period=max&api_key=YOUR_API_KEY");
const data = await res.json();